Company Filing History:
Years Active: 2021-2023
Title: Frances L Johnson: Innovator in Melanoma Treatment
Introduction
Frances L Johnson is a notable inventor based in Iowa City, IA, who has made significant contributions to the field of medical research, particularly in the treatment of melanoma. With a total of two patents to her name, Johnson's work focuses on innovative compositions and methods aimed at combating hyperproliferative disorders.
Latest Patents
Johnson's latest patents include groundbreaking inventions that provide compositions, kits, and methods for treating melanoma. One of her inventions involves an agent that increases the expression of MCR1 and an MCR1 ligand, which is crucial for treating drug-resistant melanoma. The invention also introduces a melanoma-targeting conjugate, represented by Formula I: T-L-X, where T is a MCR1 ligand, L is a linker, and X is an anti-cancer composition. This conjugate is designed for the therapeutic treatment of hyperproliferative disorders, showcasing Johnson's commitment to advancing cancer treatment methodologies.
Career Highlights
Frances L Johnson is affiliated with the University of Iowa Research Foundation, where she continues to engage in innovative research. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from melanoma and other related conditions.
Collaborations
Johnson collaborates with esteemed colleagues, including Michael K Schultz and Somya Kapoor, who contribute to her research endeavors. Their combined expertise enhances the development of effective treatment strategies in the fight against melanoma.
Conclusion
Frances L Johnson's contributions to melanoma treatment through her innovative patents and collaborative efforts highlight her role as a significant figure in medical research. Her work not only advances scientific understanding but also offers hope for improved therapeutic options for patients.